Bruker Stock News

Explosives and Narcotics Trace Detection Technology(ETD) Market forecast to 2027 The Global Explosives and Narcotics Trace Detection Technology(ETD) Market report provides information about the Global industry, including valuable facts and figures. This research study explores the Global Market in detail such as industry chain structures, raw material suppliers, with manufacturing The Explosives and Narcotics Trace []

Handheld Trace Detector Market Scenario 2020-2027: The Global Handheld Trace Detector market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2014-2027. On the basis of historical data, Handheld Trace Detector market report provides key segments and their sub-segments, revenue and demand & supply data. Considering technological []

Bruker (BRKR) reports better-than-expected earnings and revenues for the third quarter of 2021 on geographical performance driving the top line.

Bruker Corp's (NASDAQ: BRKR) Q3 revenues were $608.9 million, up 19.1 Y/Y (17.8% organically) and beating the Wall Street estimate of $574.17 million. The company saw a 1% positive effect on revenu

Bruker Corporation's (BRKR) CEO Frank Laukien on Q3 2021 Results - Earnings Call Transcript

Bruker (BRKR) delivered earnings and revenue surprises of 40.00% and 5.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Bruker (NASDAQ:BRKR) reported its Q3 earnings results on Monday, November 1, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. The post 7 A-Rated Healthcare Stocks to Buy for the Long Haul appear

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The heavy selling pressure might have exhausted for Bruker (BRKR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that it has received orders for two 1.1 GHz NMR Avance Neo systems from U.S. academic institutions

Bruker posted better-than-expected second quarter results, as the company is seeing a broad recovery across its academic, applied, clinical, and industrial end-markets. Project Accelerate 2.0 is the n

The stock price of Bruker Corporation, a scientific instruments manufacturer, primarily for molecular and materials research, has seen a rise of around 12% over the last twenty-one trading days, and i

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

JoAnne Feeney, Advisors Capital Management, joins Fast Money Special Edition to discuss profitable stocks that are lesser known.